help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ATOCHINA, E. N.
Right arrow Articles by FISHER, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ATOCHINA, E. N.
Right arrow Articles by FISHER, A. B.

Am. J. Respir. Crit. Care Med., Volume 156, Number 4, October 1997, 1114-1119

Normoxic Lung Ischemia/Reperfusion Accelerates Shedding of Angiotensin Converting Enzyme from the Pulmonary Endothelium

ELENA N. ATOCHINA, VLADIMIR R. MUZYKANTOV, ABU B. AL-MEHDI, SERGEI M. DANILOV, and ARON B. FISHER

Institute for Environmental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and Departments of Anesthesiology and Pharmacology, University of Illinois at Chicago, Chicago, Illinois

Normoxic lung ischemia/reperfusion (I/R) leads to oxidative injury of the pulmonary tissue. We analyzed angiotensin-converting enzyme (ACE) in perfused rat lungs upon I/R in order to assess the endothelial injury produced. I/R led to a time-dependent increase in ACE activity in the perfusate, from 145 ± 14 mU to 252 ± 1 mU, and to reduction of ACE activity in the lung tissue homogenate, from 29.7 ± 2.3 U to 22.7 ± 1.7 U. About 80% of ACE activity in control and I/R rat lungs was associated with an aqueous phase of extracted perfusates, thus indicating that I/R accelerates shedding of the hydrophilic form of ACE from the plasma membrane. To specifically assess ACE localized on the luminal surface of the pulmonary endothelium, we perfused rat lungs with a radiolabeled monoclonal antibody (mAb) to ACE (anti-ACE mAb 9B9). Pulmonary uptake of mAb 9B9 with I/R was reduced from 32.1 ± 1.7% to 24.8 ± 0.9%. In contrast, I/R led to a marked increase in the pulmonary uptake of nonspecific [125I]IgG, from 0.17 ± 0.02% to 0.67 ± 0.04%. Lung wet weight was equal to 0.78 ± 0.08% of body weight in the I/R group versus 0.57 ± 0.02% at the control level. The observed increase in [125I]IgG uptake and wet lung weight indicate that I/R causes an increase in lung vascular permeability. These results indicate that normoxic lung I/R induces injury to the pulmonary vascular endothelium.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
E. G. Votta-Velis, R. D. Minshall, D. J. Visintine, M. Castellon, and I. V. Balyasnikova
Propofol Attenuates Endotoxin-Induced Endothelial Cell Injury, Angiotensin-Converting Enzyme Shedding, and Lung Edema
Anesth. Analg., November 1, 2007; 105(5): 1363 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Nowak, S. Weih, R. Metzger, R. F. Albrecht II, S. Post, P. Hohenberger, M.-M. Gebhard, and S. M. Danilov
Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L162 - L169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. K. Sharma, L. G. Fernandez, A. S. Awad, I. L. Kron, and V. E. Laubach
Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-{alpha} during pulmonary ischemia-reperfusion injury
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L105 - L113.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
I. V. Balyasnikova, D. J. Visintine, H. B. Gunnerson, C. Paisansathan, V. L. Baughman, R. D. Minshall, and S. M. Danilov
Propofol Attenuates Lung Endothelial Injury Induced by Ischemia-Reperfusion and Oxidative Stress
Anesth. Analg., April 1, 2005; 100(4): 929 - 936.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. S. Maxey, R. I. Enelow, B. Gaston, I. L. Kron, V. E. Laubach, and A. Doctor
Tumor necrosis factor-{alpha} from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 541 - 547.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
Y.-T. Lu, P.-G. Chen, and S. F. Liu
Time course of lung ischemia-reperfusion-induced ICAM-1 expression and its role in ischemia-reperfusion lung injury
J Appl Physiol, August 1, 2002; 93(2): 620 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. NOWAK, M. KAMLER, M. BOCK, J. MOTSCH, S. HAGL, H. JAKOB, and M.-M. GEBHARD
Bronchial Artery Revascularization Affects Graft Recovery after Lung Transplantation
Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 216 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Christofidou-Solomidou, G. G. Pietra, C. C. Solomides, E. Arguiris, D. Harshaw, G. A. Fitzgerald, S. M. Albelda, and V. R. Muzykantov
Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs
Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L794 - L805.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society 		  ATS Clinical Skills Tests